<DOC>
	<DOCNO>NCT00627302</DOCNO>
	<brief_summary>To evaluate effect PEG-400 Systane quality vision LASIK .</brief_summary>
	<brief_title>Efficacy PEG-400 Systane Artificial Tears ( Alcon ) Quality Vision</brief_title>
	<detailed_description />
	<criteria>Males female &gt; 21 year old Scheduled undergo bilateral LASIK Likely complete study visit able provide inform consent Prior current use topical cyclosporine within last 1 year Known contraindication study medication ingredient Ocular disorder Active ocular disease uncontrolled systemic disease Active ocular allergy Complications time surgery</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Quality Vision</keyword>
</DOC>